Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204, Reus, Spain.
Department of Pathology, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira I Virgili, Av. Dr. Josep Laporte 2, 43204, Reus, Spain.
Sci Rep. 2022 Oct 17;12(1):17384. doi: 10.1038/s41598-022-22145-9.
Since the beginning of the COVID-19 pandemic and until September 2021, Spain suffered five waves of infection, the latter being related to the expansion of the Delta variant and with a high incidence. A vaccination campaign began in December 2020 and by the end of the fifth wave 77.3% of people had been fully vaccinated. Examining the changing dynamics of COVID-19 pandemic and its impact on outcomes among those hospitalized is essential. Our objective was to ascertain any differences in the characteristics and outcomes of hospitalized patients during that period compared to previous waves. We prospectively enrolled 200 consecutively admitted hospital patients from each wave and collected their clinical and demographic data from the medical records, including symptoms, comorbidities, deaths and whether they needed to be admitted to the Intensive Care Unit to receive assisted ventilation. We found that patients in the fifth wave were considerably younger than before, and the mortality rate fell from 22.5 to 2.0%. Admissions to the Intensive Care Unit decreased from 10 to 2%. Patients in the fifth wave had fewer comorbidities, and the age of the patients who died was higher than those who survived. Our results show a marked improvement in patient outcomes in the fifth wave, suggesting success of the vaccination campaign despite the explosion in cases due to the Delta variant.
自 COVID-19 大流行开始到 2021 年 9 月,西班牙经历了五波感染,最后一波与 Delta 变异株的传播有关,发病率较高。2020 年 12 月开始接种疫苗,到第五波结束时,77.3%的人已完全接种疫苗。研究 COVID-19 大流行的变化动态及其对住院患者结局的影响至关重要。我们的目的是确定与之前的波相比,在此期间住院患者的特征和结局是否存在差异。我们前瞻性地纳入了每个波的 200 名连续入院的住院患者,并从病历中收集了他们的临床和人口统计学数据,包括症状、合并症、死亡以及是否需要入住重症监护病房接受辅助通气。我们发现第五波的患者明显年轻,死亡率从 22.5%降至 2.0%。入住重症监护病房的人数从 10 人减少到 2 人。第五波患者的合并症较少,死亡患者的年龄高于幸存患者。我们的结果表明,尽管 Delta 变异株导致病例激增,但疫苗接种运动取得了成功,第五波患者的结局明显改善。